Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

American Healthcare REIT (AHR) EBIT (2016 - 2025)

American Healthcare REIT (AHR) has disclosed EBIT for 10 consecutive years, with -$400.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIT rose 8.4% year-over-year to -$400.4 million, compared with a TTM value of -$1.6 billion through Dec 2025, down 0.81%, and an annual FY2025 reading of $10.2 million, up 100.6% over the prior year.
  • EBIT was -$400.4 million for Q4 2025 at American Healthcare REIT, up from -$412.1 million in the prior quarter.
  • Across five years, EBIT topped out at -$31.6 million in Q3 2021 and bottomed at -$530.2 million in Q2 2021.
  • Average EBIT over 5 years is -$364.5 million, with a median of -$390.2 million recorded in 2022.
  • Peak annual rise in EBIT hit 64.62% in 2021, while the deepest fall reached 4051.48% in 2021.
  • Year by year, EBIT stood at -$343.6 million in 2021, then decreased by 15.55% to -$397.1 million in 2022, then skyrocketed by 46.92% to -$210.8 million in 2023, then crashed by 107.4% to -$437.1 million in 2024, then grew by 8.4% to -$400.4 million in 2025.
  • Business Quant data shows EBIT for AHR at -$400.4 million in Q4 2025, -$412.1 million in Q3 2025, and -$379.9 million in Q2 2025.